Lloyd Inc. Recalls Thyro-Tab Tablets Due to Quality Deviations
Lloyd Inc. of Iowa is recalling bulk Thyro-Tab 0.125 mg tablets due to cGMP deviations and insufficient stability data.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II and involves cGMP deviations with insufficient stability data, but no specific injuries, illnesses, or deaths are reported in the source text, fitting the criteria for a moderate severity voluntary precautionary recall.
Plain-English summary
Lloyd Inc. of Iowa is recalling 13,460,920 tablets of Lloyd Thyro-Tab 0.125 mg. The product was packaged in 150,000-tablet bulk drums for repackaging and is a prescription medication. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.
The recall was initiated due to current Good Manufacturing Practice (cGMP) deviations. Following a quality review of stability failures in previous lots, the firm determined there is insufficient data to confirm that other lots are not affected. The bulk product was distributed to Forest Laboratories, Inc. in St. Louis, MO, which repackaged the product into 100-tablet bottles. Distribution was made to 75 customers nationwide and in Puerto Rico.
Affected lots include HA27811, HC27811 (Exp Apr-13); HD35311, HA00512, HB00512 (Exp Jul-13); HA04412 (Exp Aug-13); and HD06212 (Exp Sep-13). Consumers and healthcare providers should stop using the product and contact their pharmacist or physician for guidance on alternative treatment options.
The recalled product
- Product
- Lloyd Thyro-Tab 0.125 mg., packaged in 150,000-tablet bulk drums (2/75,000-tablet bags/drum) for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.
- Manufacturer
- Lloyd Inc. of Iowa
- Category
- Drug — Prescription Medication
- Affected units
- 13,460,920
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (11)
- Lot #: HA27811
- HC27811
- Exp Apr-13
- HD35311
- HA00512
- HB00512
- exp Jul-13
- HA04412
- Exp Aug-13
- HD06212
- Exp Sep-13.
Distribution
Part of a larger recall action
This product is one of 20 recalled by Lloyd Inc. of Iowa under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 20 products in this recall →Related recalls
Same manufacturer · Lloyd Inc. of Iowa
See all →- ModerateLloyd Inc. Recalls Thyro-Tab Tablets Due to cGMP Deviations
FDA (Drugs) · 2013-05-29
- ModerateLloyd Inc. Recalls Levothroid Tablets Due to Quality Deviations
FDA (Drugs) · 2013-05-29
- ModerateLloyd Inc. Recalls Thyro-Tab Tablets Due to Quality Control Deviations
FDA (Drugs) · 2013-05-29
- ModerateLloyd Inc. Recalls Levothroid Tablets Due to Stability Failures
FDA (Drugs) · 2013-05-29
- ModerateLloyd Inc. Recalls Thyro-Tab Tablets Due to Quality Deviations
FDA (Drugs) · 2013-05-29
Same hazard · quality deviation
See all →- ModerateNarcan Nasal Spray Recalled for Temperature Excursions During Storage
FDA (Drugs) · 2021-06-02
- ModerateCardinal Health Recalls Meloxicam Tablets Due to Temperature Excursions
FDA (Drugs) · 2021-06-02
- ModerateCardinal Health Recalls LYRICA Capsules Due to Temperature Excursions
FDA (Drugs) · 2021-06-02
- ModerateCardinal Health Recalls Advair HFA Inhalers Due to Temperature Excursions
FDA (Drugs) · 2021-06-02
- ModerateCardinal Health Recalls Oseltamivir Phosphate Oral Suspension Due to Temperature Excursions
FDA (Drugs) · 2021-06-02